Transaktionen anzeigen
Gesundheitswesen

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Shield is a de-risked, specialty pharmaceutical company focused on commercializing its lead product, Feraccru®/Accrufer®, a novel, non-salt-based oral therapy for adults with iron deficiency with or without anemia.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as the joint broker on this transaction.

DIENSTLEISTUNG
Beschaffung von Kapital
PARTEIEN

Sprechen Sie mit dem Deal Team

 Geoff  Nash

Geoff Nash

Partner
London, Grossbritannien
Oaklins Cavendish

Transaktionen

SulAmérica and Rede D’Or São Luiz have announced a combination
Finanzdienstleistungen | Gesundheitswesen

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Mehr erfahren
Laboratoire Dazont has been acquired by SBM Company
Gesundheitswesen

Laboratoire Dazont has been acquired by SBM Company

The shareholders of Laboratoire Dazont have sold the company to SBM Company.

Mehr erfahren
Change Financial (ASX:CCA) has raised US$4 million
Finanzdienstleistungen

Change Financial (ASX:CCA) has raised US$4 million

Change Financial has completed a capital raise to help accelerate product enhancement, repay its debt, provide working capital and cover the costs of the offer.

Mehr erfahren